Eighth Edition of the AJCC Cancer Staging Manual: Breast Cancer

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Annals of Surgical Oncology

• Publication date

  2018-04-18

• Fields of study

  Medicine

• Identifiers
  DOI 10.1245/s10434-018-6486-6PMID 29671136
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Validation of the 8th AJCC prognostic staging system for breast cancer in a population-based setting

  2018cited by this paper
• Validation Study of the American Joint Committee on Cancer Eighth Edition Prognostic Stage Compared With the Anatomic Stage in Breast Cancer

  2017cited by this paper
• Reducing chemotherapy use in clinically high-risk, genomically low-risk pN0 and pN1 early breast cancer patients: five-year data from the prospective, randomised phase 3 West German Study Group (WSG) PlanB trial

  2017cited by this paper
• Clinical outcomes in patients with node-negative breast cancer treated based on the recurrence score results: evidence from a large prospectively designed registry

  2017cited by this paper
• 70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer.

  2016cited by this paper
• Prospective Validation of a 21-Gene Expression Assay in Breast Cancer.

  2015cited by this paper
• Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update.

  2013cited by this paper
• Prediction of late distant recurrence in patients with oestrogen-receptor-positive breast cancer: a prospective comparison of the breast-cancer index (BCI) assay, 21-gene recurrence score, and IHC4 in the TransATAC study population.

  2013cited by this paper
• American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer.

  2010cited by this paper
• American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer.

  2006cited by this paper
• Molecular portraits of human breast tumours

  2000cited by this paper

• Co-existence of fibroadenoma, intraductal carcinoma and invasive ductal carcinoma in the unilateral breast mass: a case report and literature review.

  2026cites this paper
• Survival Outcomes With or Without Risk-Reducing Mastectomy in BRCA1 and BRCA2 Pathogenic Variant Carriers.

  2026cites this paper
• Clinical staging and profiling of affective disorders.

  2026cites this paper
• Chemo-prAIdict Breast: A deep learning solution for predicting residual disease on biopsies of breast cancer patients treated with neoadjuvant chemotherapy.

  2026cites this paper
• Deep-learning-based breast cancer stage prediction from H&E-stained whole-slide images in resource-constrained settings

  2026cites this paper
• Molecular subtypes of breast carcinoma and their association with clinicopathological parameters

  2026cites this paper
• Ultrasound viscosity imaging empowers BI-RADS: toward precise breast lesion diagnosis and analysis of HER2 status

  2026cites this paper
• Clinical Applications of Immunogenomics in Hepatocellular Carcinoma.

  2026cites this paper
• Comparative analysis of clinicopathological characteristics and prognosis between E-cadherin-negative breast lymphoepithelioma-like carcinoma and E-cadherin-negative invasive lobular carcinoma.

  2026cites this paper
• Radiotherapy Strategies for Stage II Breast Cancer With Lymphovascular Invasion After Mastectomy

  2026cites this paper
• Breast Cancer in Cape Verde: Clinical-Molecular Profile and Impact of an International Treatment Partnership.

  2026cites this paper
• Predictors of Pathological Complete Response to Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer: Development and Validation of a Clinical-Inflammatory Nomogram.

  2026cites this paper
• Choosing the right animal model for sarcoma research

  2026cites this paper
• Adjuvant pegylated liposomal doxorubicin versus epirubicin sequential paclitaxel in triple-negative breast cancer: comparable efficacy with a distinct safety profile.

  2026cites this paper
• Axillary nodal evaluation in patients with breast cancer – When, why and how?

  2025cites this paper
• Breast-Conserving Surgery Versus Modified Radical Mastectomy in the Management of Non-metastatic Inflammatory Breast Cancer: A Systematic Review and Meta-Analysis

  2025cites this paper
• The Hippo Pathway in Metaplastic Breast Carcinoma: Prognostic Significance and Therapeutic Implications

  2025cites this paper
• Clinical and Pathological Characteristics of the Mammary Paget’s Disease: A Single-Center Retrospective Study in Japan

  2025cites this paper
• Calcifications Affect Pathologic Complete Response and MRI Prediction after Neoadjuvant Chemotherapy in Human Epidermal Growth Factor Receptor 2-positive Breast Cancer.

  2025cites this paper
• Integrating PET/CT-derived heterogeneity indices and composite risk scores improves prognostic stratification in breast cancer

  2025cites this paper
• Contralateral Axillary Metastasis With Synchronous Ipsilateral Axillary Metastasis From Occult Breast Cancer: A Case Report With a Review of the Literature

  2025cites this paper
• Examining the Interrelationships of Lymphedema with Pain, Physical Function, and Demographic and Medical Variables in Women with Breast Cancer and Pain.

  2025cites this paper
• HPV–driven breast carcinogenesis: associations with tumor severity, Ki67 expression and metastasis

  2025cites this paper
• Adenoid cystic carcinoma of the breast with aggressive behavior: A case report and review of the literature

  2025cites this paper
• Predicting Axillary Lymph Node Metastasis in Breast Cancer Using Ultrasound and Machine Learning with SHAP

  2025cites this paper
• Correlation of paracancerous area ultrasound characteristics and the 21-gene recurrence score: the clinical value for early-stage luminal A invasive breast cancer

  2025cites this paper
• Systemic Immune Profiling Reveals Candidate Biomarkers in Luminal A Breast Cancer: A Comparative Pilot Study

  2025cites this paper
• Exploring the characteristics of gut microbiota in the development and progression of early-stage colorectal cancer based on metagenomic sequencing

  2025cites this paper
• Development of a Bayesian Hierarchical Model for Medical Resource-Limited Settings: Prediction of Treatment Efficacy in Breast Cancer Patients in Kenya

  2025cites this paper
• Clinicopathological Profile and Outcome of Mammary Paget’s Disease with and Without Invasive Breast Cancer in a Tertiary Referral Center in a Developing Country

  2025cites this paper
• Nuevo método de heterogeneidad para predecir la supervivencia en el cáncer de mama triple negativo no metastásico

  2025cites this paper
• Stage at diagnosis and tumor characteristics among young women and men with breast cancer, in Ethiopia and Sweden, a descriptive cross-sectional study

  2025cites this paper
• Single-cell analysis reveals tumour size as a key driver of immune cell profile alterations in primary breast tumours and corresponding lymph nodes

  2025cites this paper
• Binary classification of gynecological cancers based on ATR-FTIR spectroscopy and machine learning using urine samples

  2025cites this paper
• Factors influencing pathological complete response to neoadjuvant chemotherapy in resectable breast cancer: A retrospective study

  2025cites this paper
• Baseline risk variability by eligibility criteria in Cohort 1 of the monarchE trial for high-risk HR-positive, HER2-negative breast cancer

  2025cites this paper
• Impact of routine FDG-PET/CT on locoregional treatment decisions in breast cancer patients receiving preoperative systemic therapy

  2025cites this paper
• The clinical potential of PDL-1 pathway and some related micro-RNAs as promising diagnostic markers for breast cancer

  2025cites this paper
• Metabolic characterization and radiomics-based composite model for breast cancer immune microenvironment types using 18F-FDG PET/CT

  2025cites this paper
• Effect of post-mastectomy radiation therapy on survival in breast cancer with lymph nodes micrometastases: a meta-analysis and systematic review

  2025cites this paper
• Molecular and Clinicopathological Characteristics of Invasive Breast Cancers with HER2-ultralow Expression.

  2025cites this paper
• Developing Cancer Quality of Care Indicators to Quantify the Impact of a Global Destabilization of the Care System (COLLAT-COVID)

  2025cites this paper
• Navigating discrepancies: The assessment of residual lymphovascular invasion in breast carcinoma after neoadjuvant treatment

  2025cites this paper
• Artificial Intelligence-based Digital Pathology Assessment of CD44s Expression in Breast Cancer

  2025cites this paper
• Neoadjuvant chemotherapy with or without metformin in early-stage or locally advanced (non-metastatic) triple negative breast cancer—an open-label phase 2 randomized controlled trial

  2025cites this paper
• Modification of the nuclear pleomorphism score in the Modified Bloom-Richardson grading for invasive breast cancer

  2025cites this paper
• The impact of anthropometric measurements on radiotherapy planning for patients with breast cancer

  2025cites this paper
• Decision‐making in breast pathology reporting: the effect of clinical relevant thresholds

  2025cites this paper
• De-Escalation of Treatment in Women Aged ≥80 Years with Breast Cancer: A Retrospective Analysis from Two Breast Centers

  2025cites this paper
• Applicability of Oncotype DX Testing in a Diverse Breast Cancer Population in Hawaii

  2025cites this paper
• HER2-low breast cancer in routine practice: a nationwide study of diagnostic variability across pathology laboratories.

  2025cites this paper
• BC-predict: mining of signal biomarkers and production of models for early-stage breast cancer subtyping and prognosis

  2025influential citation
• A Comprehensive Study of Invasive Breast Cancer in Egyptians: Histological Subtypes and Prognostic Indicators

  2025cites this paper
• Mastering Low-Cost Sentinel Lymph Node Biopsy using Fluorescein Sodium and Methylene Blue Dye: Evaluating its Learning Curve in Breast Cancer Surgery

  2025cites this paper
• Fusing Domains for Tumor Detection in Frozen Section Histopathology Using Joint Feature Alignment and Self-Knowledge Distillation

  2025cites this paper
• GNB2 promotes breast cancer progression by up-regulating HSPA5/GPX4 and inhibiting ferroptosis.

  2025cites this paper
• Factors associated with late diagnosis of breast cancer among women in Botswana.

  2025cites this paper
• Do Not Rush to Omit Sentinel Lymph Node Biopsy for Early Breast Cancer Patients.

  2025cites this paper
• Attitude and Practices Towards Breast Cancer Among Undergraduate Female Pharmacy Students in Pakistan

  2025influential citation
• Efficacy and Safety of Neoadjuvant TQB2102 in Locally Advanced or Early Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: A Randomized, Open-Label, Multicenter, Phase II Trial

  2025cites this paper
• The role of artificial intelligence-based foundation models and “copilots” in cancer pathology: potential and challenges

  2025cites this paper
• Multicatheter interstitial brachytherapy-delivered APBI as single-fraction treatment in older breast cancer patients: A feasibility retrospective institutional analysis.

  2025cites this paper
• Application of a simple skin flap to repair large defects in a patient with radiotherapy‑induced skin squamous cell carcinoma after breast cancer surgery: A case report

  2025cites this paper
• Prediction of axillary lymph node metastasis in T1 breast cancer using diffuse optical tomography, strain elastography and molecular markers

  2025cites this paper
• Prognostic analysis of N3 locally advanced breast cancer according to the 8th edition of AJCC clinical stage: a propensity-matched SEER analysis

  2025influential citation
• A Nomogram Based on S100A7 and Clinicopathological Characteristics to Predict the Efficacy of Neoadjuvant Chemotherapy in Breast Cancer: A Retrospective Study

  2025cites this paper
• Exploring the clinical and histopathological characteristics on breast phyllodes tumors predictors and prognosis in a real world

  2025cites this paper
• Novel heterogeneity method for predicting survival in non-metastatic triple-negative breast cancer.

  2025cites this paper
• Prognosis of nodal micrometastasis in resectable pN0 non-small cell lung cancer

  2025cites this paper
• Baseline 18F-FDG PET/CT for predicting pathological response to neoadjuvant chemotherapy and prognosis in locally advanced breast cancer patients: analysis of tumor and lymphoid organs metabolic parameters

  2025cites this paper
• Canine, Feline, and Murine Mammary Tumors as a Model for Translational Research in Breast Cancer

  2025cites this paper
• The Impact of the February 6 Kahramanmaraş Earthquake Disaster on Breast Cancer

  2025cites this paper
• Quality-of-Life and Oncological Outcomes in Male Breast Cancer: Insights from an Extensive 20-Year Experience

  2025cites this paper
• Analysis of prognosis and related influencing factors of different surgical approaches for early cervical cancer

  2025cites this paper
• Comparative efficacy of indocyanine green and Tc-99m for sentinel lymph node biopsy in breast cancer: Upfront surgery and post-neoadjuvant chemotherapy

  2025cites this paper
• Serum Enzymes and Pathologic Complete Response to the Addition of Targeted Therapy in Neoadjuvant Chemotherapy for HER2-Positive Breast Cancer Patients

  2025cites this paper
• High Expression of Calreticulin Affected the Tumor Microenvironment and Correlated With Worse Prognosis in Patients With Triple-Negative Breast Cancer

  2025cites this paper
• Clinical-genomic characteristics of homologous recombination deficiency (HRD) in breast cancer: application model for practice

  2025cites this paper
• Epidemiology of surgically treated oral cancer patients in a tertiary care hospital in Bangladesh: A retrospective study

  2025influential citation
• Dysfunctional mismatch repair in patients with early triple-negative breast cancer

  2025cites this paper
• Comparison of survival outcomes for patients with Stage III vs de novo Stage IV breast cancer

  2025cites this paper
• Age and comorbidity in relation to treatment and survival outcomes in triple-negative breast cancer: A Swedish nationwide registry-based study.

  2025cites this paper
• ALDH1A1 as a Stem Cell Marker and its Correlation with the Clinico-pathological Parameters in Invasive Mammary Carcinoma

  2025cites this paper
• Tracing the history of clinical practice of liquid biopsy: a bibliometric analysis

  2025cites this paper
• Survival outcomes in trial defined high-risk hormone receptor-positive/human epidermal growth factor receptor II-negative early breast cancer: impact of adjuvant chemotherapy

  2025cites this paper
• Utility of the CPS + EG score with real-life data in patients with breast cancer undergoing neoadjuvant chemotherapy

  2025influential citation
• Paracrine Orchestration of Tumor Microenvironment Remodeling Induced by GLO1 Potentiates Lymph Node Metastasis in Breast Cancer

  2025cites this paper
• Body mass index and progesterone receptor in postmenopausal ER-positive/HER2-negative breast cancer: A nation-wide study in Korean breast cancer society and the multi-institutional cohort

  2025cites this paper
• Application of sentinel lymph nodes biopsy tracers for breast cancer after neoadjuvant chemotherapy in China: A multicenter, real-world study

  2025cites this paper
• Bipolar disorder comorbidity in breast cancer: impact of genetic risk and lifestyle characteristic on breast cancer outcomes.

  2025cites this paper
• Incidence of palliative treatment among breast cancer patients undergoing neoadjuvant therapy: an analysis of the Brazilian public health system

  2025cites this paper
• Clinicopathological observation and prognostic factors of invasive breast cancer with medullary in Xinjiang

  2025cites this paper
• Using [18F]FDG PET/CT to Identify Optimal Responders to Neoadjuvant Therapy in Breast Cancer—Results from a Prospective Patient Cohort

  2025cites this paper
• MSN/STAT3 drives cancer stemness and chemoresistance via IL-6/LPAR1 ligand receptor complex in triple-negative breast cancer

  2025cites this paper
• Metabolomic Analysis of Breast Cancer in Colombian Patients: Exploring Molecular Signatures in Different Subtypes and Stages

  2025influential citation
• Oncological outcomes of sentinel lymph node biopsy alone in patients with residual nodal disease after neoadjuvant chemotherapy for breast cancer: a systematic review and meta-analysis.

  2025cites this paper
• Germline mutation analysis and postoperative recurrence risk prediction in breast cancer patients from western China

  2025cites this paper
• SEER-based machine learning prediction of bone metastasis in breast cancer: model development and validation

  2025cites this paper
• Patient characteristics, treatment patterns, and clinical outcomes in HER2-negative early breast cancer by germline BRCA status.

  2025cites this paper
• Understanding metastasis mixed-treatment responses through genomic analyses

  2025cites this paper